Powell-JacksonJKennedyPWhitcombeEMWellerROPreeceMANewsom-DavisJ. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet1985;2:244–6.
2.
KochTKBergBODe ArmondSJGravinaRF. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. N Engl J Med1985;313:731–3.
3.
EllisCJKatifiHWellerRO. A further British case of growth hormone induced Creutzfeldt-Jacob disease. J Neurol Neurosurg Psychiatry1992;55:1200–2.
4.
KelnarCJH. Pride and prejudice - stature in perspective. Acta Paediatr Scand (Suppl) 1990;370:5–15.
5.
KelnarCJH. Growth. London: Medicine International, 1993;217–23.
6.
LyallEGHCroftonPMStirlingHFKelnarCJH. Albuminuric growth failure. A case of Munchausen syndrome by proxy. Acta Paediatrica1992;81:373–6.
7.
ShahAStanhopeRMatthewD. Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ1992;304:173–4.
8.
Albertsson-WiklandKRosbergS. Analyses of 24-hour growth hormone profiles in children: relation to growth. J Clin Endocrinol Metab1988;67:493–500.
9.
HindmarshPCSmithPBrookCGDMatthewsDR. The relationship between height velocity and growth hormone secretion in short pre-pubertal children. Clin Endocrinol1987;27:581–97.
10.
AhmedSShaletSBeardwellG. The effects of cranial irradiation on growth hormone secretion. Acta Paediatr Scand1986;75:255–60.
11.
Albertson-WiklandKLanneringBMarkyIMellandaLWannholtU. A longitudinal study on growth and spontaneous growth hormone secretion in children with irradiated brain tumours. Acta Paedriatr Scand1987;76:966.
12.
CowellCTQuigleyCAMooreBKirkJABerginMJimenezM. Growth and growth hormone therapy of children treated for leukaemia. Acta Paediatr Scand Suppl1988;343:152–61.
13.
Ogilvy-StuartALRyderWDJGattamaneniHRClaytonPEShaletSM. Growth hormone and tumour recurrence. BMJ1992;304:1601–5.
14.
KaplanSLUnderwoodLEAugustGPBellJJBlethenSCBlizzardRM. Clinical studies with recombinant DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet1986;i:697–700.
15.
StanhopeRBuchananCRFennGCPreeceMA. Double blind placebo controlled trial of oxandrolone in the treatment of boys with constitutional delay of growth and puberty. Arch Dis Child1988;63:501–5.
16.
ButlerGESellarREWalkerRFHendryMKelnarCJHWuFCW. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth. J Clin Endocrinol Metab1992;75:37–44.
StirlingHFWuFCWScarthLGKelnarCJH. A double-blind placebo controlled study of growth hormone (GH) treatment in prepubertal short children without GH deficiency. Horm Res1991;35(suppl 2):31 [Abstract 119].
19.
StirlingHFWuFCWScarthLGKelnarCJH. Treatment of short prepubertal boys without significant growth delay: growth hormone (GH) or oxandrolone, singly or in combination?Horm Res1991;35(suppl 2):32[Abstract 122].
20.
StirlingHFWuFCWScarthLGKelnarCJH. Treatment of delayed puberty in boys: growth hormone (GH) or testosterone undecanoate (TU), singly or in combination?Horm Res1991;35(suppl 2):42 [Abstract 164].